DK585886A - Immunstimulerende middel og anvendelse deraf - Google Patents

Immunstimulerende middel og anvendelse deraf

Info

Publication number
DK585886A
DK585886A DK585886A DK585886A DK585886A DK 585886 A DK585886 A DK 585886A DK 585886 A DK585886 A DK 585886A DK 585886 A DK585886 A DK 585886A DK 585886 A DK585886 A DK 585886A
Authority
DK
Denmark
Prior art keywords
immunstimental
agents
muramyldipeptide
exhibits
active ingredient
Prior art date
Application number
DK585886A
Other languages
Danish (da)
English (en)
Other versions
DK585886D0 (da
Inventor
Koichiro Ootsu
Giichi Goto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK585886D0 publication Critical patent/DK585886D0/da
Publication of DK585886A publication Critical patent/DK585886A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK585886A 1985-12-24 1986-12-05 Immunstimulerende middel og anvendelse deraf DK585886A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29147185 1985-12-24

Publications (2)

Publication Number Publication Date
DK585886D0 DK585886D0 (da) 1986-12-05
DK585886A true DK585886A (da) 1987-06-25

Family

ID=17769299

Family Applications (1)

Application Number Title Priority Date Filing Date
DK585886A DK585886A (da) 1985-12-24 1986-12-05 Immunstimulerende middel og anvendelse deraf

Country Status (10)

Country Link
US (1) US4780313A (fr)
EP (1) EP0228833B1 (fr)
JP (1) JPS62228026A (fr)
AT (1) ATE66613T1 (fr)
AU (1) AU601957B2 (fr)
CA (1) CA1285479C (fr)
DE (1) DE3681145D1 (fr)
DK (1) DK585886A (fr)
IL (1) IL80927A0 (fr)
PH (1) PH25112A (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643565A (en) * 1985-09-20 1997-07-01 Chiron Corporation Human IL-2 as a vaccine adjuvant
US5503841A (en) * 1985-09-20 1996-04-02 Cetus Oncology Corporation Human IL-2 as a vaccine adjuvant
AU603820B2 (en) * 1986-08-13 1990-11-29 Takeda Chemical Industries Ltd. Antitumor agent
IL83350A0 (en) * 1986-08-13 1987-12-31 Takeda Chemical Industries Ltd Pharmaceutical compositions comprising interleukin and intterferon active substances
US4938956A (en) * 1987-04-01 1990-07-03 International Minerals & Chemical Corp. Synergistic immunostimulating composition and method
AU609524B2 (en) * 1987-09-02 1991-05-02 Daiichi Pharmaceutical Co., Ltd. Method for preventing or treating thrombocytopenia
US4895835A (en) * 1987-11-20 1990-01-23 Nisshin Oil Mills, Ltd. Muramyl peptide derivatives and use thereof
US4950647A (en) * 1988-10-04 1990-08-21 Nucleic Acid Research Institute T cell immunopotentiator
DE3902021A1 (de) * 1989-01-20 1990-07-26 Entec Verwendung von antipeptidergen mitteln, gegebenenfalls in kombination mit anti-androgenen mitteln zur behandlung des humanen prostatakarzinoms
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
ATE192651T1 (de) * 1989-09-25 2000-05-15 Univ Utah Res Found Verwendung von steroidhormonen in zubereitungen zur induzierung von t-zell-lymphokin-erzeugung
US5250296A (en) * 1990-11-29 1993-10-05 Takeda Chemical Industries, Ltd. Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
FR2684878B1 (fr) * 1991-12-12 1994-02-11 Roussel Uclaf Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation.
US5449691A (en) * 1991-12-31 1995-09-12 Sterling Winthrop Inc. 3,4-disubstituted anilines-immunomodulating agents
US5258407A (en) * 1991-12-31 1993-11-02 Sterling Winthrop Inc. 3,4-disubstituted phenols-immunomodulating agents
FR2702659B1 (fr) * 1993-03-19 1995-08-25 Vacsyn Sa Compositions pour l'application en thérapeutique humaine, caractérisées par l'association d'un muramyl-peptide à une cytokine.
EP0689449B1 (fr) * 1993-03-19 2002-10-30 Vacsyn S.A. Compositions pour l'application en therapeutique humaine, caracterisees par l'association d'un muramyl-peptide a une cytokine
JPH08510751A (ja) * 1993-05-27 1996-11-12 エントレメッド インコーポレイテッド 癌及び過増殖性疾患を治療するための組成物及び方法
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US6008319A (en) * 1996-12-23 1999-12-28 University Of Southern California Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
EP1490481A4 (fr) * 2001-12-14 2005-12-07 Centocor Inc Lignees de cellules clonales de myelomes utilisables pour la production de proteines dans un milieu defini chimiquement
US20030166147A1 (en) * 2001-12-14 2003-09-04 Lee Chichang Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
US20040152170A1 (en) * 2001-12-14 2004-08-05 Lee Chichang Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1563561A (en) * 1976-06-23 1980-03-26 Daiichi Seiyaku Co Muramyldipeptide derivatives and process for the preparation thereof
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン２を含有してなる癌治療剤
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
JPS60115528A (ja) * 1983-11-28 1985-06-22 Takeda Chem Ind Ltd ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物
IL76360A0 (en) * 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins

Also Published As

Publication number Publication date
DE3681145D1 (de) 1991-10-02
DK585886D0 (da) 1986-12-05
AU601957B2 (en) 1990-09-27
EP0228833B1 (fr) 1991-08-28
US4780313A (en) 1988-10-25
CA1285479C (fr) 1991-07-02
JPS62228026A (ja) 1987-10-06
EP0228833A2 (fr) 1987-07-15
AU6618986A (en) 1987-06-25
PH25112A (en) 1991-02-19
IL80927A0 (en) 1987-03-31
ATE66613T1 (de) 1991-09-15
EP0228833A3 (en) 1988-12-14

Similar Documents

Publication Publication Date Title
DK585886A (da) Immunstimulerende middel og anvendelse deraf
DK175487A (da) Farmaceutisk aktive 2-thiomethyl-substitueret-1,4-dihydro-pyridiner
ES554125A0 (es) Procedimiento de preparar hidroxamatos farmaceuticamente activos.
DE3673114D1 (de) Zerstaeuber und dessen dochtanordnung.
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
DE3689246T2 (de) Physiologisch aktives Polypeptid BUF-3.
DE69014498T2 (de) Hyposensibilisierende wirksame Substanz.
NO890795D0 (no) Hudbehandlingspreparat.
BR8602204A (pt) Valvula cardiaca
DK0385279T3 (da) Biologisk aktive midler samt præparater og materialer, der indeholder de biologisk aktive midler
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
DE3682960D1 (de) Pharmazeutische praeparate.
NO870533L (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
BR8802557A (pt) Agente fisiologicamente ativo para uso agricola
NO860733L (no) N-(2-klor-4-trifluormethylfenyl)-3-trifluormethyl-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette.
DK394084D0 (da) Fysiologisk aktive praeparater
IT8821300A0 (it) Procedimento di preparazione di morniflumato e analoghi.
DE3675679D1 (de) Menschliche bauchspeichelelastase.
ES552501A0 (es) Procedimiento y dispositivo para esterilizar aparatos o materilaes medicos.
DE3881198D1 (de) Antiviraler wirkstoff.
DK303886D0 (da) Aktive forbindelser
DK674187A (da) Aktive forbindelser
IT1216742B (it) Dispositivo e procedimento per la realizzazione estemporanea di testdiagnostici quantitativi sul sangue intero.
DK511687A (da) Farmaceutisk praeparat, samt fremstilling og anvendelse heraf
FR2587217B1 (fr) Preparations pharmaceutiques immunomodulantes

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment